Combination of omalizumab and bee venom immunotherapy: does it work?
Asia Pacific Allergy
;
(4): e2-2018.
Artículo
en Inglés
| WPRIM
| ID: wpr-750131
ABSTRACT
Bee venom immunotherapy (b-VIT) can be combined with omalizumab therapy in order to suppress systemic reactions developing due to b-VIT itself. Omalizumab acts as a premedication and gains time for the immunotherapy to develop its immunomodulatory effects. However, the combination of omalizumab and b-VIT is not always effective enough. Herein we present a patient in whom successful immunotherapy cannot be achieved with combination of omalizumab to b-VIT.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Premedicación
/
Venenos de Abeja
/
Abejas
/
Omalizumab
/
Anafilaxia
/
Inmunoterapia
Límite:
Humanos
Idioma:
Inglés
Revista:
Asia Pacific Allergy
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS